Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein ...
Oral presentation will highlight previously reported data demonstrating early stabilization or improvement in mFARS scores ...
WIVB Buffalo on MSN
Parkinson’s Foundation celebrates movement with annual fundraiser
BUFFALO, N.Y. (WIVB) — Participants gathered in Williamsville Saturday for a celebration of movement, as the Parkinson’s ...
Another potential blockbuster just joined AbbVie's drug portfolio.
Parkinson’s disease is a brain disorder that gradually affects movement and many other body functions. It develops as nerve ...
Vima Therapeutics, a clinical-stage biotechnology company focused on oral therapies for movement disorders, today announced that four poster presentations will be featured at the 2026 International ...
Poster Title: Long-Term Open-Label Data on the GCase Modulator GT-02287 ( Rexaceract) in People with Parkinson’s Disease Location : Hall D, 3 rd Floor, E-Poster Station 12 The International Parkinson ...
Tavapadon (Juvmo) is a new once-daily pill for Parkinson’s motor symptoms. Here’s how it works, who it may help and what to ...
Tavapadon, a treatment for Parkinson’s disease recently approved by the FDA, provides a novel option for healthcare providers ...
The annual POP Walk (People of Parkinson's) is happening on Saturday, October 3rd at First Baptist Church of Augusta ...
Two devastating movement disorders, Parkinson’s disease and multiple system atrophy, often look so similar in the clinic that ...
Neuroscience imaging company IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB) has presented new research at a European conference ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results